Like the PCR test, the antigen test is done through the nose but obtaining the result is much faster -
SYSPEO / SIPA
Swiss pharmaceutical giant Roche will launch a new high volume antigen test.
Called Elecsys SARS-CoV-2 Antigen, this test intended to be performed in the laboratory can detect the presence of specific coronavirus antigens in just 18 minutes, the Swiss group said in a statement.
The latter should help unclog health systems.
Its launch is scheduled for the end of the year in countries accepting the European CE conformity marking.
The Swiss group also intends to file an application for accelerated authorization for the American market.
Alternative to PCR tests
The test, which is also done by a nasal swab, can be used as an alternative to PCR tests when these are not available or if the testing capacity is under pressure to help healthcare professionals identify patients with symptoms. of the disease, said the Swiss group.
This test is intended to be performed on so-called Cobas machines, present in many hospitals and laboratories, which can process up to 300 samples per hour and provide a result in 18 minutes, he detailed.
20% of his income
The world number one in oncology, Roche also relies on a large division specializing in diagnostics, which contributes more than 20% of its revenues.
Since the start of the health crisis, the Swiss group has already launched eight tests for coronavirus infections, including one to distinguish Covid-19 from influenza.
Health
Coronavirus: The High Authority for Health validates antigenic tests, which are faster
Health
Coronavirus: Johnson & Johnson vaccine trial suspended due to sick participant
Screening
Pharmaceutical industry
Covid 19
Coronavirus
Laboratory
Health